Clinical Utility of Positron Emission Tomography/Computed Tomography in the Evaluation of Suspected Recurrent Ovarian Cancer in the Setting of Normal CA-125 Levels
@article{Bhosale2010ClinicalUO, title={Clinical Utility of Positron Emission Tomography/Computed Tomography in the Evaluation of Suspected Recurrent Ovarian Cancer in the Setting of Normal CA-125 Levels}, author={P. Bhosale and Silanath Peungjesada and W. Wei and C. Levenback and K. Schmeler and E. Rohren and H. Macapinlac and R. Iyer}, journal={International Journal of Gynecologic Cancer}, year={2010}, volume={20}, pages={936 - 944} }
Objectives: This study was conducted to estimate the accuracy of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) as compared with contrast-enhanced CT (CECT) in detecting cancer in patients who have normal cancer antigen (CA)-125 (<35 U/dL) but are suspected of having a recurrent disease based on clinical symptoms. Methods: We retrospectively reviewed the records of patients who had undergone primary cytoreductive surgery and subsequently underwent CECT… CONTINUE READING
Topics from this paper
50 Citations
Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma
- Medicine
- Abdominal Radiology
- 2017
- 4
Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patients.
- Medicine
- Journal of the Turkish German Gynecological Association
- 2015
- 13
Diagnostic value of integrated 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in recurrent epithelial ovarian cancer: accuracy of patient selection for secondary cytoreduction in 134 patients
- Medicine
- Journal of gynecologic oncology
- 2018
- 1
- Highly Influenced
- PDF
Role of 18F-FDG PET/CT in the detection of ovarian cancer recurrence in the setting of normal tumor markers
- Medicine
- 2014
- 3
- PDF
Positron Emission Tomography/Computed Tomography in Platinum-sensitive Recurrent Ovarian Cancer: A Single-center Italian Study
- Medicine
- AntiCancer Research
- 2020
Clinical and Survival Impact of FDG PET in Patients with Suspicion of Recurrent Ovarian Cancer: A 6-Year Follow-Up
- Medicine
- Front. Med.
- 2015
- 11
- PDF
Revisiting the Clinical Value of 18F-FDG PET/CT in Detection of Recurrent Epithelial Ovarian Carcinomas: Correlation With Histology, Serum CA-125 Assay, and Conventional Radiological Modalities
- Medicine
- Clinical nuclear medicine
- 2012
- 36
Is there an impact of 18F-FDG PET/CT on the surveillance and clinical management of recurrent ovarian cancer? Research based on a large sample in a single PET/CT center
- Medicine
- Nuclear medicine communications
- 2014
- 20
Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy
- Medicine
- Nuclear medicine communications
- 2016
- 13
- PDF
Accuracy of Positron Emission Tomography/Computed Tomography in the Diagnosis and Restaging for Recurrent Ovarian Cancer: A Meta-Analysis
- Medicine
- International Journal of Gynecologic Cancer
- 2013
- 44
References
SHOWING 1-10 OF 53 REFERENCES
Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings
- Medicine
- European Journal of Nuclear Medicine and Molecular Imaging
- 2006
- 92
Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
- Medicine
- Gynecologic oncology
- 2007
- 142
[F-18-FDG positron emission tomography in the diagnosis of ovarian recurrence. Comparison with CT scan and CA 125].
- Medicine
- Revista espanola de medicina nuclear
- 2003
- 11
Positron emission tomography/computed tomography introduction in the clinical management of patients with suspected recurrence of ovarian cancer: a cost-effectiveness analysis.
- Medicine
- European journal of cancer care
- 2009
- 20
Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review.
- Medicine
- Gynecologic oncology
- 2002
- 118
Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma
- Medicine
- European Radiology
- 2000
- 154
[Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
- Medicine
- Zhonghua fu chan ke za zhi
- 2007
- 10
Influence of 2-(18F) Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography on Recurrent Ovarian Cancer Diagnosis and on Selection of Patients for Secondary Cytoreductive Surgery
- Medicine
- International Journal of Gynecologic Cancer
- 2009
- 51
2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer.
- Medicine
- Gynecologic oncology
- 2001
- 136
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry.
- Medicine
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- 2008
- 338
- PDF